1 Study Coverage 1.1 Virus Like Particles Product Introduction 1.2 Market Segments 1.3 Key Virus Like Particles Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Virus Like Particles Market Size Growth Rate by Type 1.4.2 Adeno-Associated Virus 1.4.3 HIV 1.4.4 Hepatitis B Virus 1.4.5 Hepatitis C Virus 1.4.6 Other 1.5 Market by Application 1.5.1 Global Virus Like Particles Market Size Growth Rate by Application 1.5.2 Vaccines 1.5.3 Mycoviruses 1.5.4 Virus Research 1.5.5 Therapeutic and Imaging Agents 1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Virus Like Particles Market Size, Estimates and Forecasts 2.1.1 Global Virus Like Particles Revenue 2015-2026 2.1.2 Global Virus Like Particles Sales 2015-2026 2.2 Global Virus Like Particles, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Virus Like Particles Historical Market Size by Region (2015-2020) 2.3.1 Global Virus Like Particles Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Virus Like Particles Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Virus Like Particles Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Virus Like Particles Sales Forecast by Region (2021-2026) 2.4.2 Global Virus Like Particles Revenue Forecast by Region (2021-2026) 3 Global Virus Like Particles Competitor Landscape by Players 3.1 Global Top Virus Like Particles Sales by Manufacturers 3.1.1 Global Virus Like Particles Sales by Manufacturers (2015-2020) 3.1.2 Global Virus Like Particles Sales Market Share by Manufacturers (2015-2020) 3.2 Global Virus Like Particles Manufacturers by Revenue 3.2.1 Global Virus Like Particles Revenue by Manufacturers (2015-2020) 3.2.2 Global Virus Like Particles Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Virus Like Particles Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Virus Like Particles Revenue in 2019 3.2.5 Global Virus Like Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Virus Like Particles Price by Manufacturers 3.4 Global Virus Like Particles Manufacturing Base Distribution, Product Types 3.4.1 Virus Like Particles Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Virus Like Particles Product Type 3.4.3 Date of International Manufacturers Enter into Virus Like Particles Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Virus Like Particles Market Size by Type (2015-2020) 4.1.1 Global Virus Like Particles Sales by Type (2015-2020) 4.1.2 Global Virus Like Particles Revenue by Type (2015-2020) 4.1.3 Virus Like Particles Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Virus Like Particles Market Size Forecast by Type (2021-2026) 4.2.1 Global Virus Like Particles Sales Forecast by Type (2021-2026) 4.2.2 Global Virus Like Particles Revenue Forecast by Type (2021-2026) 4.2.3 Virus Like Particles Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Virus Like Particles Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Virus Like Particles Market Size by Application (2015-2020) 5.1.1 Global Virus Like Particles Sales by Application (2015-2020) 5.1.2 Global Virus Like Particles Revenue by Application (2015-2020) 5.1.3 Virus Like Particles Price by Application (2015-2020) 5.2 Virus Like Particles Market Size Forecast by Application (2021-2026) 5.2.1 Global Virus Like Particles Sales Forecast by Application (2021-2026) 5.2.2 Global Virus Like Particles Revenue Forecast by Application (2021-2026) 5.2.3 Global Virus Like Particles Price Forecast by Application (2021-2026) 6 China by Players, Type and Application 6.1 China Virus Like Particles Market Size YoY Growth 2015-2026 6.1.1 China Virus Like Particles Sales YoY Growth 2015-2026 6.1.2 China Virus Like Particles Revenue YoY Growth 2015-2026 6.1.3 China Virus Like Particles Market Share in Global Market 2015-2026 6.2 China Virus Like Particles Market Size by Players (International and Local Players) 6.2.1 China Top Virus Like Particles Players by Sales (2015-2020) 6.2.2 China Top Virus Like Particles Players by Revenue (2015-2020) 6.3 China Virus Like Particles Historic Market Review by Type (2015-2020) 6.3.1 China Virus Like Particles Sales Market Share by Type (2015-2020) 6.3.2 China Virus Like Particles Revenue Market Share by Type (2015-2020) 6.3.3 China Virus Like Particles Price by Type (2015-2020) 6.4 China Virus Like Particles Market Estimates and Forecasts by Type (2021-2026) 6.4.1 China Virus Like Particles Sales Forecast by Type (2021-2026) 6.4.2 China Virus Like Particles Revenue Forecast by Type (2021-2026) 6.4.3 China Virus Like Particles Price Forecast by Type (2021-2026) 6.5 China Virus Like Particles Historic Market Review by Application (2015-2020) 6.5.1 China Virus Like Particles Sales Market Share by Application (2015-2020) 6.5.2 China Virus Like Particles Revenue Market Share by Application (2015-2020) 6.5.3 China Virus Like Particles Price by Application (2015-2020) 6.6 China Virus Like Particles Market Estimates and Forecasts by Application (2021-2026) 6.6.1 China Virus Like Particles Sales Forecast by Application (2021-2026) 6.6.2 China Virus Like Particles Revenue Forecast by Application (2021-2026) 6.6.3 China Virus Like Particles Price Forecast by Application (2021-2026) 7 North America 7.1 North America Virus Like Particles Market Size YoY Growth 2015-2026 7.2 North America Virus Like Particles Market Facts & Figures by Country 7.2.1 North America Virus Like Particles Sales by Country (2015-2020) 7.2.2 North America Virus Like Particles Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Virus Like Particles Market Size YoY Growth 2015-2026 8.2 Europe Virus Like Particles Market Facts & Figures by Country 8.2.1 Europe Virus Like Particles Sales by Country 8.2.2 Europe Virus Like Particles Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Virus Like Particles Market Size YoY Growth 2015-2026 9.2 Asia Pacific Virus Like Particles Market Facts & Figures by Country 9.2.1 Asia Pacific Virus Like Particles Sales by Region (2015-2020) 9.2.2 Asia Pacific Virus Like Particles Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Virus Like Particles Market Size YoY Growth 2015-2026 10.2 Latin America Virus Like Particles Market Facts & Figures by Country 10.2.1 Latin America Virus Like Particles Sales by Country 10.2.2 Latin America Virus Like Particles Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Virus Like Particles Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Virus Like Particles Market Facts & Figures by Country 11.2.1 Middle East and Africa Virus Like Particles Sales by Country 11.2.2 Middle East and Africa Virus Like Particles Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 GlaxoSmithKline 12.1.1 GlaxoSmithKline Corporation Information 12.1.2 GlaxoSmithKline Description and Business Overview 12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 12.1.4 GlaxoSmithKline Virus Like Particles Products Offered 12.1.5 GlaxoSmithKline Recent Development 12.2 Merck 12.2.1 Merck Corporation Information 12.2.2 Merck Description and Business Overview 12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Merck Virus Like Particles Products Offered 12.2.5 Merck Recent Development 12.3 Novavax 12.3.1 Novavax Corporation Information 12.3.2 Novavax Description and Business Overview 12.3.3 Novavax Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Novavax Virus Like Particles Products Offered 12.3.5 Novavax Recent Development 12.4 Takeda 12.4.1 Takeda Corporation Information 12.4.2 Takeda Description and Business Overview 12.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Takeda Virus Like Particles Products Offered 12.4.5 Takeda Recent Development 12.5 Medicago 12.5.1 Medicago Corporation Information 12.5.2 Medicago Description and Business Overview 12.5.3 Medicago Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Medicago Virus Like Particles Products Offered 12.5.5 Medicago Recent Development 12.6 MedImmune 12.6.1 MedImmune Corporation Information 12.6.2 MedImmune Description and Business Overview 12.6.3 MedImmune Sales, Revenue and Gross Margin (2015-2020) 12.6.4 MedImmune Virus Like Particles Products Offered 12.6.5 MedImmune Recent Development 12.7 TechnoVax 12.7.1 TechnoVax Corporation Information 12.7.2 TechnoVax Description and Business Overview 12.7.3 TechnoVax Sales, Revenue and Gross Margin (2015-2020) 12.7.4 TechnoVax Virus Like Particles Products Offered 12.7.5 TechnoVax Recent Development 12.8 Agilvax 12.8.1 Agilvax Corporation Information 12.8.2 Agilvax Description and Business Overview 12.8.3 Agilvax Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Agilvax Virus Like Particles Products Offered 12.8.5 Agilvax Recent Development 12.9 Allergy Therapeutics 12.9.1 Allergy Therapeutics Corporation Information 12.9.2 Allergy Therapeutics Description and Business Overview 12.9.3 Allergy Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Allergy Therapeutics Virus Like Particles Products Offered 12.9.5 Allergy Therapeutics Recent Development 12.10 Serum Institute of India 12.10.1 Serum Institute of India Corporation Information 12.10.2 Serum Institute of India Description and Business Overview 12.10.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Serum Institute of India Virus Like Particles Products Offered 12.10.5 Serum Institute of India Recent Development 12.11 GlaxoSmithKline 12.11.1 GlaxoSmithKline Corporation Information 12.11.2 GlaxoSmithKline Description and Business Overview 12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 12.11.4 GlaxoSmithKline Virus Like Particles Products Offered 12.11.5 GlaxoSmithKline Recent Development 12.12 Cytos Biotechnology 12.12.1 Cytos Biotechnology Corporation Information 12.12.2 Cytos Biotechnology Description and Business Overview 12.12.3 Cytos Biotechnology Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Cytos Biotechnology Products Offered 12.12.5 Cytos Biotechnology Recent Development 12.13 ANGANY Genetics 12.13.1 ANGANY Genetics Corporation Information 12.13.2 ANGANY Genetics Description and Business Overview 12.13.3 ANGANY Genetics Sales, Revenue and Gross Margin (2015-2020) 12.13.4 ANGANY Genetics Products Offered 12.13.5 ANGANY Genetics Recent Development 12.14 CPL Biologicals 12.14.1 CPL Biologicals Corporation Information 12.14.2 CPL Biologicals Description and Business Overview 12.14.3 CPL Biologicals Sales, Revenue and Gross Margin (2015-2020) 12.14.4 CPL Biologicals Products Offered 12.14.5 CPL Biologicals Recent Development 12.15 Xiamen Innovax Biotech 12.15.1 Xiamen Innovax Biotech Corporation Information 12.15.2 Xiamen Innovax Biotech Description and Business Overview 12.15.3 Xiamen Innovax Biotech Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Xiamen Innovax Biotech Products Offered 12.15.5 Xiamen Innovax Biotech Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Virus Like Particles Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Virus Like Particles Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Virus Like Particles Market Segments Table 2. Ranking of Global Top Virus Like Particles Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Virus Like Particles Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of Adeno-Associated Virus Table 5. Major Manufacturers of HIV Table 6. Major Manufacturers of Hepatitis B Virus Table 7. Major Manufacturers of Hepatitis C Virus Table 8. Major Manufacturers of Other Table 9. Global Virus Like Particles Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 10. Global Virus Like Particles Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 11. Global Virus Like Particles Sales by Regions 2015-2020 (K Pcs) Table 12. Global Virus Like Particles Sales Market Share by Regions (2015-2020) Table 13. Global Virus Like Particles Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Virus Like Particles Sales Forecast by Region (2021-2026) (K Pcs) Table 15. Global Virus Like Particles Sales by Manufacturers (2015-2020) (K Pcs) Table 16. Global Virus Like Particles Sales Share by Manufacturers (2015-2020) Table 17. Global Virus Like Particles Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Virus Like Particles by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virus Like Particles as of 2019) Table 19. Virus Like Particles Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Virus Like Particles Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Virus Like Particles Price (2015-2020) (USD/Pcs) Table 22. Virus Like Particles Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Virus Like Particles Product Type Table 24. Date of International Manufacturers Enter into Virus Like Particles Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Virus Like Particles Sales by Type (2015-2020) (K Pcs) Table 27. Global Virus Like Particles Sales Share by Type (2015-2020) Table 28. Global Virus Like Particles Revenue by Type (2015-2020) (US$ Million) Table 29. Global Virus Like Particles Revenue Share by Type (2015-2020) Table 30. Virus Like Particles Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 31. Global Virus Like Particles Sales Share by Type (2021-2026) Table 32. Global Virus Like Particles Sales by Application (2015-2020) (K Pcs) Table 33. Global Virus Like Particles Sales Share by Application (2015-2020) Table 34. Global Virus Like Particles Sales Share by Application (2021-2026) Table 35. Global Virus Like Particles Sales Market Share Forecast by Application (2021-2026) Table 36. Global Virus Like Particles Revenue by Application (2015-2020) (US$ Million) Table 37. Global Virus Like Particles Revenue Market Share Forecast by Application (2021-2026) Table 38. China Virus Like Particles Sales (K Pcs) of Key Companies (2015-2020) Table 39. China Virus Like Particles Sales Share by Company (2015-2020) Table 40. China Virus Like Particles Revenue (US$ Million) by Company (2015-2020) Table 41. China Virus Like Particles Sales (K Pcs) by Type (2015-2020) Table 42. China Virus Like Particles Sales Share by Type (2015-2020) Table 43. China Virus Like Particles Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. China Virus Like Particles Price (K Pcs) by Type (2015-2020) Table 45. China Virus Like Particles Sales (K Pcs) by Type (2021-2026) Table 46. China Virus Like Particles Sales Share by Type (2021-2026) Table 47. China Virus Like Particles Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. China Virus Like Particles Revenue Share by Type (2021-2026) Table 49. China Virus Like Particles Price (K Pcs) by Type (2021-2026) Table 50. China Virus Like Particles Sales (K Pcs) by Application (2015-2020) Table 51. China Virus Like Particles Sales Share by Application (2015-2020) Table 52. China Virus Like Particles Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. China Virus Like Particles Sales (K Pcs) by Application (2021-2026) Table 54. China Virus Like Particles Sales Share by Application (2021-2026) Table 55. China Virus Like Particles Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. China Virus Like Particles Revenue Share by Application (2021-2026) Table 57. North America Virus Like Particles Sales by Country (2015-2020) (K Pcs) Table 58. North America Virus Like Particles Sales Market Share by Country (2015-2020) Table 59. North America Virus Like Particles Revenue by Country (2015-2020) (US$ Million) Table 60. North America Virus Like Particles Revenue Market Share by Country (2015-2020) Table 61. Europe Virus Like Particles Sales by Country (2015-2020) (K Pcs) Table 62. Europe Virus Like Particles Sales Market Share by Country (2015-2020) Table 63. Europe Virus Like Particles Revenue by Country (2015-2020) (US$ Million) Table 64. Europe Virus Like Particles Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific Virus Like Particles Sales by Region (2015-2020) (K Pcs) Table 66. Asia Pacific Virus Like Particles Sales Market Share by Region (2015-2020) Table 67. Asia Pacific Virus Like Particles Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific Virus Like Particles Revenue Market Share by Region (2015-2020) Table 69. Latin America Virus Like Particles Sales by Country (2015-2020) (K Pcs) Table 70. Latin America Virus Like Particles Sales Market Share by Country (2015-2020) Table 71. Latin Americaa Virus Like Particles Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America Virus Like Particles Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Virus Like Particles Sales by Country (2015-2020) (K Pcs) Table 74. Middle East and Africa Virus Like Particles Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa Virus Like Particles Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa Virus Like Particles Revenue Market Share by Country (2015-2020) Table 77. GlaxoSmithKline Corporation Information Table 78. GlaxoSmithKline Description and Business Overview Table 79. GlaxoSmithKline Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 80. GlaxoSmithKline Virus Like Particles Product Table 81. GlaxoSmithKline Recent Development Table 82. Merck Corporation Information Table 83. Merck Description and Business Overview Table 84. Merck Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 85. Merck Product Table 86. Merck Recent Development Table 87. Novavax Corporation Information Table 88. Novavax Description and Business Overview Table 89. Novavax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 90. Novavax Product Table 91. Novavax Recent Development Table 92. Takeda Corporation Information Table 93. Takeda Description and Business Overview Table 94. Takeda Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 95. Takeda Product Table 96. Takeda Recent Development Table 97. Medicago Corporation Information Table 98. Medicago Description and Business Overview Table 99. Medicago Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 100. Medicago Product Table 101. Medicago Recent Development Table 102. MedImmune Corporation Information Table 103. MedImmune Description and Business Overview Table 104. MedImmune Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 105. MedImmune Product Table 106. MedImmune Recent Development Table 107. TechnoVax Corporation Information Table 108. TechnoVax Description and Business Overview Table 109. TechnoVax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 110. TechnoVax Product Table 111. TechnoVax Recent Development Table 112. Agilvax Corporation Information Table 113. Agilvax Description and Business Overview Table 114. Agilvax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 115. Agilvax Product Table 116. Agilvax Recent Development Table 117. Allergy Therapeutics Corporation Information Table 118. Allergy Therapeutics Description and Business Overview Table 119. Allergy Therapeutics Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 120. Allergy Therapeutics Product Table 121. Allergy Therapeutics Recent Development Table 122. Serum Institute of India Corporation Information Table 123. Serum Institute of India Description and Business Overview Table 124. Serum Institute of India Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 125. Serum Institute of India Product Table 126. Serum Institute of India Recent Development Table 127. GeoVax Labs Corporation Information Table 128. GeoVax Labs Description and Business Overview Table 129. GeoVax Labs Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 130. GeoVax Labs Product Table 131. GeoVax Labs Recent Development Table 132. Cytos Biotechnology Corporation Information Table 133. Cytos Biotechnology Description and Business Overview Table 134. Cytos Biotechnology Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 135. Cytos Biotechnology Product Table 136. Cytos Biotechnology Recent Development Table 137. ANGANY Genetics Corporation Information Table 138. ANGANY Genetics Description and Business Overview Table 139. ANGANY Genetics Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 140. ANGANY Genetics Product Table 141. ANGANY Genetics Recent Development Table 142. CPL Biologicals Corporation Information Table 143. CPL Biologicals Description and Business Overview Table 144. CPL Biologicals Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 145. CPL Biologicals Product Table 146. CPL Biologicals Recent Development Table 147. Xiamen Innovax Biotech Corporation Information Table 148. Xiamen Innovax Biotech Description and Business Overview Table 149. Xiamen Innovax Biotech Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 150. Xiamen Innovax Biotech Product Table 151. Xiamen Innovax Biotech Recent Development Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 153. Key Challenges Table 154. Market Risks Table 155. Main Points Interviewed from Key Virus Like Particles Players Table 156. Virus Like Particles Customers List Table 157. Virus Like Particles Distributors List Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Virus Like Particles Product Picture Figure 2. Global Virus Like Particles Sales Market Share by Type in 2020 & 2026 Figure 3. Adeno-Associated Virus Product Picture Figure 4. HIV Product Picture Figure 5. Hepatitis B Virus Product Picture Figure 6. Hepatitis C Virus Product Picture Figure 7. Other Product Picture Figure 8. Global Virus Like Particles Sales Market Share by Application in 2020 & 2026 Figure 9. Vaccines Figure 10. Mycoviruses Figure 11. Virus Research Figure 12. Therapeutic and Imaging Agents Figure 13. Other Figure 14. Virus Like Particles Report Years Considered Figure 15. Global Virus Like Particles Market Size 2015-2026 (US$ Million) Figure 16. Global Virus Like Particles Sales 2015-2026 (K Pcs) Figure 17. Global Virus Like Particles Market Size Market Share by Region: 2020 Versus 2026 Figure 18. Global Virus Like Particles Sales Market Share by Region (2015-2020) Figure 19. Global Virus Like Particles Sales Market Share by Region in 2019 Figure 20. Global Virus Like Particles Revenue Market Share by Region (2015-2020) Figure 21. Global Virus Like Particles Revenue Market Share by Region in 2019 Figure 22. Global Virus Like Particles Sales Share by Manufacturer in 2019 Figure 23. The Top 10 and 5 Players Market Share by Virus Like Particles Revenue in 2019 Figure 24. Virus Like Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 25. Global Virus Like Particles Sales Market Share by Type (2015-2020) Figure 26. Global Virus Like Particles Sales Market Share by Type in 2019 Figure 27. Global Virus Like Particles Revenue Market Share by Type (2015-2020) Figure 28. Global Virus Like Particles Revenue Market Share by Type in 2019 Figure 29. Global Virus Like Particles Market Share by Price Range (2015-2020) Figure 30. Global Virus Like Particles Sales Market Share by Application (2015-2020) Figure 31. Global Virus Like Particles Sales Market Share by Application in 2019 Figure 32. Global Virus Like Particles Revenue Market Share by Application (2015-2020) Figure 33. Global Virus Like Particles Revenue Market Share by Application in 2019 Figure 34. China Virus Like Particles Sales Growth Rate 2015-2026 (K Pcs) Figure 35. China Virus Like Particles Revenue Growth Rate 2015-2026 (US$ Million) Figure 36. China Virus Like Particles Market Share in Global Market 2015-2026 Figure 37. China 5 and 10 Largest Virus Like Particles Players Market Share by Revenue in Virus Like Particles in 2019 Figure 38. China Virus Like Particles Revenue Share by Type (2015-2020) Figure 39. China Virus Like Particles Revenue Growth Rate by Type in 2015 & 2019 Figure 40. China Virus Like Particles Revenue Share by Application (2015-2020) Figure 41. China Virus Like Particles Revenue Growth Rate by Application in 2015 & 2019 Figure 42. North America Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs) Figure 43. North America Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million) Figure 44. North America Virus Like Particles Sales Market Share by Country in 2019 Figure 45. North America Virus Like Particles Revenue Market Share by Country in 2019 Figure 46. U.S. Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 47. U.S. Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Canada Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 49. Canada Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Europe Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs) Figure 51. Europe Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million) Figure 52. Europe Virus Like Particles Sales Market Share by Country in 2019 Figure 53. Europe Virus Like Particles Revenue Market Share by Country in 2019 Figure 54. Germany Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 55. Germany Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. France Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 57. France Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. U.K. Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 59. U.K. Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Italy Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 61. Italy Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Russia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 63. Russia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Asia Pacific Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs) Figure 65. Asia Pacific Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million) Figure 66. Asia Pacific Virus Like Particles Sales Market Share by Region in 2019 Figure 67. Asia Pacific Virus Like Particles Revenue Market Share by Region in 2019 Figure 68. China Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 69. China Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Japan Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 71. Japan Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. South Korea Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 73. South Korea Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. India Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 75. India Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Australia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Australia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Taiwan Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 79. Taiwan Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Indonesia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 81. Indonesia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Thailand Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 83. Thailand Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 84. Malaysia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 85. Malaysia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 86. Philippines Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 87. Philippines Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Vietnam Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 89. Vietnam Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Latin America Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs) Figure 91. Latin America Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million) Figure 92. Latin America Virus Like Particles Sales Market Share by Country in 2019 Figure 93. Latin America Virus Like Particles Revenue Market Share by Country in 2019 Figure 94. Mexico Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 95. Mexico Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 96. Brazil Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 97. Brazil Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 98. Argentina Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 99. Argentina Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Middle East and Africa Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs) Figure 101. Middle East and Africa Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million) Figure 102. Middle East and Africa Virus Like Particles Sales Market Share by Country in 2019 Figure 103. Middle East and Africa Virus Like Particles Revenue Market Share by Country in 2019 Figure 104. Turkey Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 105. Turkey Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Saudi Arabia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 107. Saudi Arabia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 108. U.A.E Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs) Figure 109. U.A.E Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million) Figure 110. Porter's Five Forces Analysis Figure 111. Virus Like Particles Value Chain Figure 112. Channels of Distribution Figure 113. Distributors Profiles Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed

GlaxoSmithKline Merck Novavax Takeda Medicago MedImmune TechnoVax Agilvax Allergy Therapeutics Serum Institute of India GeoVax Labs Cytos Biotechnology ANGANY Genetics CPL Biologicals Xiamen Innovax Biotech